TCG Lifesciences Strategy Dinner - Ocean Prime - 18th May

What to expect

Overview of Discussion

Seamless global strategy for NCE development and API supply chain by optimizing technology, providing collective expertise, and reducing the delivery time and cost – an unmet need. The “heart of drug development” is to employ innovative technologies and collaborations across the globe, to assemble a powerful Drug Development Engine to accelerate candidates from drug discovery, PRD, scale-up through commercialization. The best way to increase the valuation of drug discovery and development pipeline and company’s portfolio is to accelerate their milestones, reduce costs while maintaining quality.

Today’s CDMO industry is lacking a unique collective expertise in one place, utilizing ground-breaking technologies for the synthesis of architecturally complex molecules that can intercept any molecule, at any stage of development. Ultimately the know-how of phase appropriate execution, ‘shaving’ months off the development cycle time and a “one stop shop” of delivery of entire CMC management is an unmet need.

KEY TOPICS OF DISCUSSION

Big-Pharma training with Biotech mentality to “Accelerate Molecules to Medicines”
• Solving complicated CMC problems for NCEs using “First Time Right” basis, for FIH
• Minimising timelines in comparison to other CDMOs and utilising the dynamics of cost structures
• Examining global resources and addressing the transparency in IP protection
Dr. Chris H. Senanayake, Ph.D. CSO, TCG Lifesciences Pvt. Ltd. / CEO & CSO, TCG GreenChem, Inc (NJ & VA, USA)
Dr. Joseph D. Armstrong, III, Ph.D. COO, TCG GreenChem, Inc (NJ & VA, USA)

Continue topic – Big Pharma training with Biotech mentality to “Accelerate Molecules to Medicines”
• Accelerating innovative technologies embedded in Process Research and Development for API
• Partnership approaches:
1. Smooth tech transfer for API within global setting
2. Discussing the advantages of English speaking scientists, scientific project managers andengagements with client-based approaches
3. Project management is from US operations and 24 hour delivery in problem solving
Dr. Subho Roy, Ph.D, Vice President – Business Head, Clinivent Research Pvt. Ltd, A 100% subsidiary of TCG Lifesciences
Dr. Chris H. Senanayake, Ph.D, CSO, TCG Lifesciences Pvt. Ltd. / CEO & CSO, TCG GreenChem, Inc
(NJ & VA, USA)
Dr. Joseph D. Armstrong, III, Ph.D, COO, TCG GreenChem, Inc (NJ & VA, USA)

Dr. Gopal Sirasani, Director, CDMO Business Development and Technical Operations, TCG GreenChem

WHY BOOK YOUR VIP SEAT NOW?

You will be amongst 10-15 Industry thought leaders from a mix of large Pharmaceutical Institutions ensuring you are given ample opportunity to raise questions and contribute from a strategic perspective. You can wine, dine and network with industry leaders who face common challenges in 60-minute roundtable discussions that enable you to share ideas and lessons learned. The dinner will be facilitated by expert moderators, these sessions provide a valuable dialogue with peers on current challenges and topical issues. There is no media, marketing or press, just pure and honest discussion to help solve your key strategic challenges for the next 3-9 months.

Meet the Facilitators

The Dinner will be lead by our expert facilitators

Dr. Sanjoy Kumar Mahanty, Ph.D

Vice President, Head of Business Development TCG Lifesciences Pvt. Ltd

Dr. Subho Roy, Ph.D

Vice President – Business Head Clinivent Research Pvt. Ltd, A 100% subsidiary of TCG Lifesciences

Dr. Subho Roy Joined the group in 2002 and has been one of the key leadership members responsible for the growth of the company. He holds a Ph.D degree from Indian Institute of Chemical Technology, working with Dr. A.V.Rama Rao, on synthesis of natural products of biological importance and subsequently spent few years at the University of Kansas, Lawrence, USA, working with Dr. Gunda Georg for his post-doctoral studies. He has more than 20 years of Industrial experience of progressing small molecules coming out of R&D through various phases of development and taking them all the way to commercialization. He is a specialist in new process development, optimization and various other aspects of CMC. Dr. Roy has several publications to his credit and holds several European and US patents. He has played a key role in conceptualizing and designing of the manufacturing facility, “Clinivent Research Pvt. Ltd.”, a 100% subsidiary of <a href="https://www.tcgls.com/">TCG Lifesciences</a>, which has successfully completed US FDA inspection.

Dr. Chris H. Senanayake, Ph.D

CSO & CEO TCG Lifesciences Pvt. Ltd. – TCG GreenChem, Inc (NJ & VA, USA)

Dr. Senanayake is an inspirational leader with 30 years of experience in the pharmaceutical industry with extensive knowledge and experience in all drug development processes, company governance committees and commercialization. He has been instrumental in delivering several multibillion-dollar drugs in an accelerated manner to the market; CrixivanTM, LunestaTM, Formotorol and PristiqTM (Desvenlafaxine), JardianceTM and many other drugs.  He has received the prestigious Swiss Siegfried Gold Medal Award for development of practical processes for APIs and Process Chemistry via the use of sustainable and green manufacturing processes, 2010. He has >500 Publications in nationally known top scientific journals, > 150 patents for chemical processes, drug discovery and development, etc., >150 invited lectures. Currently he serves as the Board of Editors of Organic Synthesis, Advance Synthesis of Catalysis, Organic Process Research and Development, Asian Journal of Organic Chemistry and Beilstein Journal of Organic Chemistry.

Dr. Joseph D. Armstrong, III, Ph.D

COO TCG GreenChem, Inc (NJ & VA, USA)

Dr. Armstrong is a high energy scientific and executive leader with 28 years of experience at Merck & Co., Inc. in Process Research, Formulation Development and Project Management with deep knowledge and experience of all drug discovery and development processes to support IND to NDA filings. As the Merck Preclinical Integration Lead (Process R&D, Formulation R&D, DMPK, Safety Assessment, and Clinical Supplies) for the merger with Schering Plough, created a multidisciplinary organization that leveraged development knowledge to accelerate identification of Preclinical Candidates and their rapid entry into the clinic and beyond. He led the cross-functional team that filed the drug JanuviaTM for the treatment of type II diabetes in < 4 years by executing new green and sustainable technologies and strategies. He led the Process R&D Team that discovered the novel asymmetric hydrogenation process for the preparation of Sitagliptin, the active ingredient in JanuviaTM . This team received the Thomas Edison award, the EU IChemE Aztra-Zeneca Award for Green Chemistry and Engineering and the US Presidential Green Chemistry Challenge Award.

Dr. Gopal Sirasani, Ph.D

Associate Vice President TCG GreenChem, Inc.

More about TCG Lifesciences

More information

At TCG, we address these needs with a proven strategy utilizing the following inherent strengths: Top tier and experienced people from big-Pharma , High end technology platforms and science, like continuous chemistry, catalysis , Large PRD group working across the globe , Operational synergies amongst group companies , Trust-based client relations and depth of engagement spanning two decades and World class facilities and infrastructure. We deliver integrated end-to-end solutions to the global life sciences’ industries.

Location

140 Seaport Blvd, Boston, MA 02210, United States

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Manufacturing TCG Boston

TCG Lifesciences Strategy Dinner – Ocean Prime – 18th May

TCG Boston

TCG Lifesciences Dinner

Overview of Discussion

KEY TOPICS OF DISCUSSION

Registration, Networking & Cocktails

Welcome & Introductions – TCG Lifesciences Dr. Sanjoy Kumar Mahanty, Ph.D. Associate Vice President, Business Development, TCG Lifesciences Pvt. Ltd.

Roundtable Discussion

Dinner

Roundtable Discussion

Closing Remarks, Coffee & Cognacs

WHY BOOK YOUR VIP SEAT NOW?

Meet the Facilitators

Dr. Sanjoy Kumar Mahanty, Ph.D

Dr. Subho Roy, Ph.D

Dr. Chris H. Senanayake, Ph.D

Dr. Joseph D. Armstrong, III, Ph.D

Dr. Gopal Sirasani, Ph.D

More about TCG Lifesciences

Location

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

Discovery to Development

Pre-Clinical